Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Landau

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Neuroimage|June 8, 2017
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's diseaseAnne Maass, Susan Landau, Suzanne L Baker, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Susan Landau, et al.
Brain : a Journal of Neurology|December 27, 2014
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Michael Donohue, et al.
Journal of Neurotrauma|March 1, 2023
Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS)Tia L Cummins, Vincent Doré, Azadeh Feizpour, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
A robust harmonization approach for cognitive data from multiple aging and dementia cohortsJoseph Giorgio, Ankeet Tanna, Maura Malpetti, et al.
Alzheimer Disease and Associated Disorders|May 28, 2025
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)José A Luchsinger, Davangere Devanand, Terry E Goldberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
Biological Psychiatry|September 27, 2020
Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression ProjectR Scott Mackin, Philip S Insel, Susan Landau, et al.
Neurobiology of Aging|September 27, 2016
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET studyClaudio Babiloni, Claudio Del Percio, Anna Caroli, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life DepressionEmma Rhodes, Philip S Insel, Meryl A Butters, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Neuroimage|June 8, 2017
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's diseaseAnne Maass, Susan Landau, Suzanne L Baker, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Susan Landau, et al.
Brain : a Journal of Neurology|December 27, 2014
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Michael Donohue, et al.
Journal of Neurotrauma|March 1, 2023
Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS)Tia L Cummins, Vincent Doré, Azadeh Feizpour, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
A robust harmonization approach for cognitive data from multiple aging and dementia cohortsJoseph Giorgio, Ankeet Tanna, Maura Malpetti, et al.
Alzheimer Disease and Associated Disorders|May 28, 2025
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)José A Luchsinger, Davangere Devanand, Terry E Goldberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal dataMark E Schmidt, Ping Chiao, Gregory Klein, et al.
Biological Psychiatry|September 27, 2020
Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression ProjectR Scott Mackin, Philip S Insel, Susan Landau, et al.
Neurobiology of Aging|September 27, 2016
Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET studyClaudio Babiloni, Claudio Del Percio, Anna Caroli, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2021
The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life DepressionEmma Rhodes, Philip S Insel, Meryl A Butters, et al.
Pageof 5